Hypoxia and Hypoxia-Inducible Factor Signaling in Muscular Dystrophies: Cause and Consequences

Total Page:16

File Type:pdf, Size:1020Kb

Hypoxia and Hypoxia-Inducible Factor Signaling in Muscular Dystrophies: Cause and Consequences International Journal of Molecular Sciences Review Hypoxia and Hypoxia-Inducible Factor Signaling in Muscular Dystrophies: Cause and Consequences Thuy-Hang Nguyen 1, Stephanie Conotte 1, Alexandra Belayew 1 , Anne-Emilie Declèves 2 , Alexandre Legrand 1 and Alexandra Tassin 1,* 1 Laboratory of Respiratory Physiology, Pathophysiology and Rehabilitation, Research Institute for Health Sciences and Technology, University of Mons, 7000 Mons, Belgium; [email protected] (T.-H.N.); [email protected] (S.C.); [email protected] (A.B.); [email protected] (A.L.) 2 Department of Metabolic and Molecular Biochemistry, Research Institute for Health Sciences and Technology, University of Mons, 7000 Mons, Belgium; [email protected] * Correspondence: [email protected] Abstract: Muscular dystrophies (MDs) are a group of inherited degenerative muscle disorders characterized by a progressive skeletal muscle wasting. Respiratory impairments and subsequent hypoxemia are encountered in a significant subgroup of patients in almost all MD forms. In response to hypoxic stress, compensatory mechanisms are activated especially through Hypoxia-Inducible Factor 1 α (HIF-1α). In healthy muscle, hypoxia and HIF-1α activation are known to affect oxidative stress balance and metabolism. Recent evidence has also highlighted HIF-1α as a regulator of myogenesis and satellite cell function. However, the impact of HIF-1α pathway modifications in MDs remains to be investigated. Multifactorial pathological mechanisms could lead to HIF-1α activation in patient skeletal muscles. In addition to the genetic defect per se, respiratory failure or blood vessel Citation: Nguyen, T.-H.; Conotte, S.; alterations could modify hypoxia response pathways. Here, we will discuss the current knowledge Belayew, A.; Declèves, A.-E.; Legrand, A.; Tassin, A. Hypoxia and about the hypoxia response pathway alterations in MDs and address whether such changes could Hypoxia-Inducible Factor Signaling influence MD pathophysiology. in Muscular Dystrophies: Cause and Consequences. Int. J. Mol. Sci. 2021, Keywords: hypoxia; myopathies; HIF-1α 22, 7220. https://doi.org/10.3390/ ijms22137220 Academic Editor: Jung-Ae Kim 1. Introduction Muscular dystrophies (MDs) are a heterogeneous group of inherited degenerative Received: 31 May 2021 muscle disorders resulting in progressive muscle weakness and dystrophic histopathology Accepted: 30 June 2021 observed on muscle biopsies. Clinically, MDs are characterized by a high variability in Published: 5 July 2021 terms of age of onset, severity, and progression. MDs are also very heterogeneous in their genetic features and the distribution of the affected muscles, including or not an impact Publisher’s Note: MDPI stays neutral on cardiac or respiratory muscles as well as extra-muscular manifestations such as insulin with regard to jurisdictional claims in resistance. published maps and institutional affil- Respiratory impairments are frequent MD clinical manifestations and associated to iations. hypoxemia in subgroups of patients [1–3]. At the tissue level, hypoxemia leads to cellular hypoxia. In primary muscle disorders, the impact of hypoxia on muscle pathophysiology remains poorly documented [4]. This is particularly surprising since several MDs are known to cause chronic hypoxemia due to hypoventilation as a consequence of respiratory Copyright: © 2021 by the authors. muscle weakness. Licensee MDPI, Basel, Switzerland. The Nobel prize in Physiology or Medicine was awarded in 2019 to William G. Kaelin This article is an open access article Jr, Peter J. Ratcliffe and Gregg L. Semenza “for their discoveries of how cells sense and distributed under the terms and adapt to oxygen availability” [5]. They uncovered the main effectors of the hypoxic conditions of the Creative Commons response, the HIF transcription factor family, and how oxygen-dependent post-translational Attribution (CC BY) license (https:// α creativecommons.org/licenses/by/ modifications of HIF-1/2 lead to their degradation in normoxic conditions and their 4.0/). activation in hypoxia. HIF factors (HIF-1, HIF-2, HIF-3) are heterodimers composed of an Int. J. Mol. Sci. 2021, 22, 7220. https://doi.org/10.3390/ijms22137220 https://www.mdpi.com/journal/ijms Int. J. Mol.Int. Sci. J.2021 Mol. ,Sci.22, 2021 7220, 21, x FOR PEER REVIEW 2 of 342 of 33 oxygen-regulated α subunit and a stable β subunit. HIF-1α and HIF-2α are considered as modifications of HIF-1/2 α lead to their degradation in normoxic conditions and their ac- the mastertivation regulators in hypoxia. of HIF the factors hypoxic (HIF-1, response HIF-2, transcriptional HIF-3) are heterodimers program. composed Under normoxic of an conditions,oxygen-regulated HIFα subunits α subunit are and constantly a stable β expressed subunit. HIF-1 butα rapidly and HIF-2 degradedα are considered by a complex as mechanism.the master They regulators are first of hydroxylated the hypoxic respon by specificse transcriptional Prolyl Hydroxylase program. Domain-containingUnder normoxic enzymesconditions, (PHD). HIF Thisα subunits reaction are is oxygen-dependent,constantly expressed sincebut rapidly the transferred degraded by hydroxyl a complex group is derivedmechanism. from They the Oare2 firstmolecule. hydroxylated This reactionby specific also Prolyl requires Hydroxylase three Domain-contain- cofactors, namely 2-oxoglutarate,ing enzymes vitamin (PHD). C, This and reaction iron [6 ].is Then,oxygen the-dependent, Von Hippel–Lindau since the transferred (pVHL) E3hydroxyl ubiquitin- ligasegroup recognizes is derived hydroxylated from the O2 molecule. HIFα forms This andreaction activates also requires their ubiquitination three cofactors, namely leading to their2-oxoglutarate, degradation by vitamin the proteasome. C, and iron [6]. By Th contrast,en, the Von under Hippel–Lindau hypoxic conditions, (pVHL) E3 PHD ubiqui- cannot tin-ligase recognizes hydroxylated HIFα forms and activates their ubiquitination leading hydroxylate HIFα because of the decreased O2 availability, allowing for HIFα stabilization, dimerizationto their degradation with HIF1 byβ, the and proteasome. translocation By contrast, into the under nucleus. hypoxic HIF conditions, factors then PHD activatecan- not hydroxylate HIFα because of the decreased O2 availability, allowing for HIFα stabili- the transcription of more than a hundred target genes through their binding to a specific zation, dimerization with HIF1β, and translocation into the nucleus. HIF factors then ac- DNAtivate sequence the transcription called Hypoxia of more Response than a hund Elementred target (HRE) genes [7 through–10] (Figure their 1binding and Table to a 1). HIF-1specificα and DNA HIF-2 sequenceα belong called to the Hypoxia basic helix-loop-helixResponse Element (bHLH)(HRE) [7– family10] (Figure of transcription 1 and Ta- factorsble and 1). HIF-1 exhibitα and a highly HIF-2α conserved belong to the structure basic helix-loop-helix and functional (bHLH) similarities. family of However,transcrip- an increasingtion factors number and ofexhibit studies a highly point conserved to differences structure in transcriptional and functional similarities. regulation However, and function in responsean increasing to hypoxia number and of instudies disease point states to differences [11]. The rolein transcriptional of HIF-3 is stillregulation debated and since its genefunction can express in response multiple to hypoxia variants and in exhibiting disease states different [11]. The activities, role of HIF-3 some is still of which debated were reportedsince as its negative gene can regulatorsexpress multiple of HIF-1/2 variantsα [ex12hibiting]. different activities, some of which were reported as negative regulators of HIF-1/2α [12]. Figure 1. Regulation of HIF pathway. Under normoxia, HIFα protein is hydroxylated by PHDs and Figuresubsequently 1. Regulation recognized of by HIF pVHL pathway. and degraded Under through normoxia, the ubiquitin–proteasome HIFα protein is hydroxylated pathway. In byhypoxia, PHDs PHD and activity subsequently is inhibited recognized by the decreased by pVHL O2 levels and degradedand thus HIF throughα hydroxylation. the ubiquitin– HIFα is proteasome pathway. In hypoxia, PHD activity is inhibited by the decreased O2 levels and thus HIFα hydroxylation. HIFα is therefore stabilized and translocated into the nucleus, dimerizes with HIF1β, and activates the expression of hypoxia responsive genes with additional transcriptional co-factors, such as CBP/P300. Ub = ubiquitin. Int. J. Mol. Sci. 2021, 22, 7220 3 of 33 Table 1. Main HIF-1α target genes and regulated pathways. Regulated Pathways HIF-1α Target Genes VEGF and VEGF receptor FLT1, Angiogenesis and erythropoiesis heme oxygenase 1, NOS 2 and 3, PDGF ALDA, ALDOC, ENO1, GAPDH, HK1, HK2, Metabolism LDH A, PFKL, PGK1, PKM, and TPI GLUT-1, 3, 4, PDK1 Proliferation and survival Cyclin G2, TGFα and β3, IGF-2 Apoptosis BNIP3/3L, P53 Myogenesis WNT signaling Compared to other oxygen-sensitive tissues such as the brain and heart, skeletal muscles tolerate hypoxia quite well because of their plasticity. Indeed, they adapt their metabolism and structural features (fiber size, muscle fiber type, mitochondrial activity, myoglobin content) as well as blood supply (capillary density) in response to hypoxia, a condition muscles encounter in non-pathological contexts e.g., physical exercise or exposure to high altitude [13–15]. Obviously, muscle adaptation will strongly depend on exercise training
Recommended publications
  • Core Transcriptional Regulatory Circuitries in Cancer
    Oncogene (2020) 39:6633–6646 https://doi.org/10.1038/s41388-020-01459-w REVIEW ARTICLE Core transcriptional regulatory circuitries in cancer 1 1,2,3 1 2 1,4,5 Ye Chen ● Liang Xu ● Ruby Yu-Tong Lin ● Markus Müschen ● H. Phillip Koeffler Received: 14 June 2020 / Revised: 30 August 2020 / Accepted: 4 September 2020 / Published online: 17 September 2020 © The Author(s) 2020. This article is published with open access Abstract Transcription factors (TFs) coordinate the on-and-off states of gene expression typically in a combinatorial fashion. Studies from embryonic stem cells and other cell types have revealed that a clique of self-regulated core TFs control cell identity and cell state. These core TFs form interconnected feed-forward transcriptional loops to establish and reinforce the cell-type- specific gene-expression program; the ensemble of core TFs and their regulatory loops constitutes core transcriptional regulatory circuitry (CRC). Here, we summarize recent progress in computational reconstitution and biologic exploration of CRCs across various human malignancies, and consolidate the strategy and methodology for CRC discovery. We also discuss the genetic basis and therapeutic vulnerability of CRC, and highlight new frontiers and future efforts for the study of CRC in cancer. Knowledge of CRC in cancer is fundamental to understanding cancer-specific transcriptional addiction, and should provide important insight to both pathobiology and therapeutics. 1234567890();,: 1234567890();,: Introduction genes. Till now, one critical goal in biology remains to understand the composition and hierarchy of transcriptional Transcriptional regulation is one of the fundamental mole- regulatory network in each specified cell type/lineage.
    [Show full text]
  • P53 Regulates Myogenesis by Triggering the Differentiation
    CORE Metadata, citation and similar papers at core.ac.uk Provided by PubMed Central p53 Regulates Myogenesis by Triggering the Differentiation Activity of pRb Alessandro Porrello, Maria Antonietta Cerone, Sabrina Coen, Aymone Gurtner, Giulia Fontemaggi, Letizia Cimino, Giulia Piaggio, Ada Sacchi, and Silvia Soddu Molecular Oncogenesis Laboratory, Regina Elena Cancer Institute, Center for Experimental Research, 00158 Rome, Italy Abstract. The p53 oncosuppressor protein regulates mary myoblasts, pRb is hypophosphorylated and prolif- cell cycle checkpoints and apoptosis, but increasing evi- eration stops. However, these cells do not upregulate dence also indicates its involvement in differentiation pRb and have reduced MyoD activity. The transduction and development. We had previously demonstrated of exogenous TP53 or Rb genes in p53-defective myo- that in the presence of differentiation-promoting stim- blasts rescues MyoD activity and differentiation poten- uli, p53-defective myoblasts exit from the cell cycle but tial. Additionally, in vivo studies on the Rb promoter do not differentiate into myocytes and myotubes. To demonstrate that p53 regulates the Rb gene expression identify the pathways through which p53 contributes at transcriptional level through a p53-binding site. to skeletal muscle differentiation, we have analyzed Therefore, here we show that p53 regulates myoblast the expression of a series of genes regulated during differentiation by means of pRb without affecting its myogenesis in parental and dominant–negative p53 cell cycle–related functions. (dnp53)-expressing C2C12 myoblasts. We found that in dnp53-expressing C2C12 cells, as well as in p53Ϫ/Ϫ pri- Key words: p53 • Rb • MyoD • differentiation • muscle Introduction The differentiation of skeletal myoblasts is characterized review, see Wright, 1992).
    [Show full text]
  • Investigation of the Underlying Hub Genes and Molexular Pathogensis in Gastric Cancer by Integrated Bioinformatic Analyses
    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.20.423656; this version posted December 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Investigation of the underlying hub genes and molexular pathogensis in gastric cancer by integrated bioinformatic analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2020.12.20.423656; this version posted December 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract The high mortality rate of gastric cancer (GC) is in part due to the absence of initial disclosure of its biomarkers. The recognition of important genes associated in GC is therefore recommended to advance clinical prognosis, diagnosis and and treatment outcomes. The current investigation used the microarray dataset GSE113255 RNA seq data from the Gene Expression Omnibus database to diagnose differentially expressed genes (DEGs). Pathway and gene ontology enrichment analyses were performed, and a proteinprotein interaction network, modules, target genes - miRNA regulatory network and target genes - TF regulatory network were constructed and analyzed. Finally, validation of hub genes was performed. The 1008 DEGs identified consisted of 505 up regulated genes and 503 down regulated genes.
    [Show full text]
  • Cellular and Developmental Control of O2 Homeostasis by Hypoxia-Inducible Factor 1␣
    Downloaded from genesdev.cshlp.org on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1a Narayan V. Iyer,1,5 Lori E. Kotch,1,5 Faton Agani,1 Sandra W. Leung,1 Erik Laughner,1 Roland H. Wenger,2 Max Gassmann,2 John D. Gearhart,3 Ann M. Lawler,3 Aimee Y. Yu,1 and Gregg L. Semenza1,4 1Center for Medical Genetics, Departments of Pediatrics and Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287-3914 USA; 2Institute of Physiology, University of Zurich-Irchel, 8057 Zurich, Switzerland; 3Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205 USA Hypoxia is an essential developmental and physiological stimulus that plays a key role in the pathophysiology of cancer, heart attack, stroke, and other major causes of mortality. Hypoxia-inducible factor 1 (HIF-1) is the only known mammalian transcription factor expressed uniquely in response to physiologically relevant levels −/− of hypoxia. We now report that in Hif1a embryonic stem cells that did not express the O2-regulated HIF-1a subunit, levels of mRNAs encoding glucose transporters and glycolytic enzymes were reduced, and cellular proliferation was impaired. Vascular endothelial growth factor mRNA expression was also markedly decreased in hypoxic Hif1a−/− embryonic stem cells and cystic embryoid bodies. Complete deficiency of HIF-1a resulted in developmental arrest and lethality by E11 of Hif1a−/− embryos that manifested neural tube defects, cardiovascular malformations, and marked cell death within the cephalic mesenchyme. In Hif1a+/+ embryos, HIF-1a expression increased between E8.5 and E9.5, coincident with the onset of developmental defects and cell death in Hif1a−/− embryos.
    [Show full text]
  • The MCK Enhancer Contains a P53 Responsive Element (P53/Anti-Oncogene/Trans-Activation) HAROLD WEINTRAUB*, STEPHEN Hauschkat, and STEPHEN J
    Proc. Natl. Acad. Sci. USA Vol. 88, pp. 4570-4571, June 1991 Biochemistry The MCK enhancer contains a p53 responsive element (p53/anti-oncogene/trans-activation) HAROLD WEINTRAUB*, STEPHEN HAUSCHKAt, AND STEPHEN J. TAPSCOTT* *Howard Hughes Medical Institute, Fred Hutchinson Cancer Research Center, 1124 Columbia Street, Seattle, WA 98104; and tDepartment of Biochemistry, University of Washington, Seattle, WA 98195 Contributed by Harold Weintraub, March 4, 1991 ABSTRACT p53 is an antioncogene that is defective or suggesting that activation may be species specific; however, absent in a large number of human tumors. Its function in levels ofprotein produced by the expression vectors were not normal cells is not known. We show that co-transfection of directly assayed in these experiments. By using an MCK- mouse p53 with muscle-specific creatine kinase-chloramphen- specific antibody, we have not been able to demonstrate icol acetyltransferase reporter gene, containing 3.3 kilobase of activation of the endogenous MCK gene in 10T1/2 cells upstream control sequence for the muscle-specfic creatine transfected with p53; in contrast 10T'/2 cells transfected with kinase gene, results in a 10- to 80-fold activation. The p53 MyoD express endogenous MCK immunoreactivity. responsive element maps to a region disinguhed from the Table 2 shows that a transforming mutant of murine p53 known MyoD binding region. Identification ofa p53 responsive (Ala -3 Val at position 135) fails to activate MCK-CAT in element should allow a more focused analysis of the effects of CV1 cells. A related mutation has lost its capacity for p53 in controlling gene activity. transactivation when fused to the DNA binding domain of GaI4 (5, 6).
    [Show full text]
  • Role of the Nuclear Receptor Rev-Erb Alpha in Circadian Food Anticipation and Metabolism Julien Delezie
    Role of the nuclear receptor Rev-erb alpha in circadian food anticipation and metabolism Julien Delezie To cite this version: Julien Delezie. Role of the nuclear receptor Rev-erb alpha in circadian food anticipation and metabolism. Neurobiology. Université de Strasbourg, 2012. English. NNT : 2012STRAJ018. tel- 00801656 HAL Id: tel-00801656 https://tel.archives-ouvertes.fr/tel-00801656 Submitted on 10 Apr 2013 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. UNIVERSITÉ DE STRASBOURG ÉCOLE DOCTORALE DES SCIENCES DE LA VIE ET DE LA SANTE CNRS UPR 3212 · Institut des Neurosciences Cellulaires et Intégratives THÈSE présentée par : Julien DELEZIE soutenue le : 29 juin 2012 pour obtenir le grade de : Docteur de l’université de Strasbourg Discipline/ Spécialité : Neurosciences Rôle du récepteur nucléaire Rev-erbα dans les mécanismes d’anticipation des repas et le métabolisme THÈSE dirigée par : M CHALLET Etienne Directeur de recherche, université de Strasbourg RAPPORTEURS : M PFRIEGER Frank Directeur de recherche, université de Strasbourg M KALSBEEK Andries
    [Show full text]
  • Androgen-Dependent Pathology Demonstrates Myopathic
    Research article Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model Zhigang Yu,1 Nahid Dadgar,1 Megan Albertelli,2 Kirsten Gruis,3 Cynthia Jordan,4 Diane M. Robins,2 and Andrew P. Lieberman1 1Department of Pathology, 2Department of Human Genetics, and 3Department of Neurology, University of Michigan Medical School, Ann Arbor, Michigan, USA. 4Department of Psychology and Neuroscience Program, Michigan State University, East Lansing, Michigan, USA. Kennedy disease, a degenerative disorder characterized by androgen-dependent neuromuscular weakness, is caused by a CAG/glutamine tract expansion in the androgen receptor (Ar) gene. We developed a mouse model of Kennedy disease, using gene targeting to convert mouse androgen receptor (AR) to human sequence while introducing 113 glutamines. AR113Q mice developed hormone and glutamine length–dependent neuromus- cular weakness characterized by the early occurrence of myopathic and neurogenic skeletal muscle pathology and by the late development of neuronal intranuclear inclusions in spinal neurons. AR113Q males unexpect- edly died at 2–4 months. We show that this androgen-dependent death reflects decreased expression of skeletal muscle chloride channel 1 (CLCN1) and the skeletal muscle sodium channel α-subunit, resulting in myotonic discharges in skeletal muscle of the lower urinary tract. AR113Q limb muscles show similar myopathic features and express decreased levels of mRNAs encoding neurotrophin-4 and glial cell line–derived neurotrophic fac- tor. These data define an important myopathic contribution to the Kennedy disease phenotype and suggest a role for muscle in non–cell autonomous toxicity of lower motor neurons. Introduction dent on the presence of androgen (13–16) and is regulated, in Kennedy disease, or spinal and bulbar muscular atrophy, is one part, by hormone-dependent retrograde transport (17, 18).
    [Show full text]
  • Myod-Cre Driven Alterations in K-Ras and P53 Lead to a Mouse Model
    bioRxiv preprint doi: https://doi.org/10.1101/2021.06.15.448607; this version posted June 15, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. MyoD-Cre driven alterations in K-Ras and p53 lead to a mouse model with histological and molecular characteristics of human rhabdomyosarcoma with direct translational applications Kengo Nakahata1, Brian W. Simons2, Enrico Pozzo3, Ryan Shuck1, Lyazat Kurenbekova1, Cristian Coarfa4,6 Tajhal D. Patel1, and Jason T. Yustein*1,5,6 1Texas Children’s Cancer and Hematology Centers and The Faris D. Virani Ewing Sarcoma Center, Baylor College of Medicine, Houston, TX 77030 2Center for Comparative Medicine, Baylor College of Medicine, Houston, TX 77030 3Translational Cardiomyology Laboratory, Stem Cell Research Institute, Stem Cell Biology and Embryology Unit, Department of Development and Regeneration, KU Leuven, Leuven, Belgium. 4Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030 5Cancer and Cell Biology Program, Baylor College of Medicine, Houston, TX 77030 6Dan L. Duncan Cancer Comprehensive Center, Baylor College of Medicine, Houston, TX 77030 *Corresponding Author Corresponding Author: Jason T. Yustein, MD, PhD 1102 Bates St., Suite 1025.07 Houston, Texas 77030 832-824-4601 (Office) [email protected] ORCID: https://orcid.org/0000-0002-2052-0527 - 1 - bioRxiv preprint doi: https://doi.org/10.1101/2021.06.15.448607; this version posted June 15, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
    [Show full text]
  • Hypoxia and Aging Eui-Ju Yeo1
    Yeo Experimental & Molecular Medicine (2019) 51:67 https://doi.org/10.1038/s12276-019-0233-3 Experimental & Molecular Medicine REVIEW ARTICLE Open Access Hypoxia and aging Eui-Ju Yeo1 Abstract Eukaryotic cells require sufficient oxygen (O2) for biological activity and survival. When the oxygen demand exceeds its supply, the oxygen levels in local tissues or the whole body decrease (termed hypoxia), leading to a metabolic crisis, threatening physiological functions and viability. Therefore, eukaryotes have developed an efficient and rapid oxygen sensing system: hypoxia-inducible factors (HIFs). The hypoxic responses are controlled by HIFs, which induce the expression of several adaptive genes to increase the oxygen supply and support anaerobic ATP generation in eukaryotic cells. Hypoxia also contributes to a functional decline during the aging process. In this review, we focus on the molecular mechanisms regulating HIF-1α and aging-associated signaling proteins, such as sirtuins, AMP-activated protein kinase, mechanistic target of rapamycin complex 1, UNC-51-like kinase 1, and nuclear factor κB, and their roles in aging and aging-related diseases. In addition, the effects of prenatal hypoxia and obstructive sleep apnea (OSA)- induced intermittent hypoxia have been reviewed due to their involvement in the progression and severity of many diseases, including cancer and other aging-related diseases. The pathophysiological consequences and clinical manifestations of prenatal hypoxia and OSA-induced chronic intermittent hypoxia are discussed in detail. Introduction chemoreceptors stimulates the neurotransmitter release 3 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; Oxygen (O2) plays critical roles in aerobic respiration pathway and modulates the activity of a neutral endo- and metabolism as the final electron acceptor of the peptidase, neprilysin (NEP), which modifies the cellular mitochondrial electron transport chain, which is respon- response to hypoxia by hydrolyzing substance P4.
    [Show full text]
  • Physical Interaction of the Retinoblastoma Protein with Human D Cyclins
    Cell, Vol. 73, 499-511, May 7, 1993, Copyright 0 1993 by Cell Press Physical Interaction of the Retinoblastoma Protein with Human D Cyclins Steven F. Dowdy,* Philip W. Hinds,’ Kenway Louie,’ into Rb- tumor cells by microinjection, viral infection, or Steven I. Reed,t Andrew Arnold,* transfection can lead to the growth arrest of these recipient and Robert A. Weinberg” cells (Huang et al., 1988; Goodrich et al., 1991; Templeton *The Whitehead Institute for Biomedical Research et al., 1991; Hinds et al., 1992). and Department of Biology Oncoproteins specified by the SV40, adenovirus, and Massachusetts Institute of Technology papilloma DNA tumor viruses have been shown to associ- Cambridge, Massachusetts 02142 ate with pRb in virus-transformed cells (Whyte et al., 1988; tThe Scripps Research Institute DeCaprio et al., 1988; Dyson et al., 1989). Oncoprotein Department of Molecular Biology binding of pRb is presumed to lead to its sequestration 10666 North Torrey Pines Road and functional inactivation. Conserved region II mutants La Jolla, California 92037 of adenovirus ElA, SV40 large T antigen, human papil- *Endocrine Unit loma E7 viral oncoproteins that have lost their ability to and Massachusetts General Hospital Cancer Center bind pflb, and other pRb-related proteins exhibit signifi- Massachusetts General Hospital cantly reduced transforming potential (Moran et al., 1986; and Harvard Medical School Lillie et al., 1987; Cherington et al., 1988; DeCaprio et al., Boston, Massachusetts 02114 1988; Moran, 1988; Smith and Ziff, 1988; Whyte et al., 1989). This suggests that binding of pRb and related pro- teins by these oncoproteins is critical to their transforming abilities.
    [Show full text]
  • MINAX Contains the Active Ingredient Metoprolol Tartrate CONSUMER MEDICINE INFORMATION
    MINAX contains the active ingredient metoprolol tartrate CONSUMER MEDICINE INFORMATION What is in this leaflet blood vessels in the body, as well as lung problems, or have had helping the heart to beat more them in the past This leaflet answers some common regularly. • You have a history of allergic questions about MINAX. It does not Your doctor will have explained why problems, including hayfever contain all of the available you are being treated with MINAX • You have low blood pressure information. and told you what dose to take. MINAX may be used either alone or • You have a very slow heartbeat It does not take the place of talking to (less than 45-50 beats/minute) your doctor or pharmacist. in combination with other medicines to treat your condition. • You have certain other heart All medicines have benefits and conditions risks. Your doctor has weighed the Ask your doctor if you have any risks of you taking MINAX against questions about why MINAX has • You have phaeochromocytoma the benefits they expect it will have been prescribed for you. (a rare tumour of the adrenal for you. Your doctor may have prescribed gland) which is not being MINAX for another reason. treated already with other If you have any concerns about medicines taking this medicine, talk to your Follow all directions given to you • You have a severe blood vessel doctor or pharmacist. by your doctor carefully. disorder causing poor Keep this leaflet with your They may differ from the circulation in the arms and legs medicine. information contained in this leaflet.
    [Show full text]
  • CORONARY ARTERY DISEASE Etiology and Pathophysiology
    806 Section 7 Problems of Oxygenation: Perfusion ing can be injured as a result of tobacco use, hyperlipidemia, hy- 493,623 pertension, diabetes, hyperhomocysteinemia, and infection (e.g., 500 433,825 Males Chlamydia pneumoniae, herpes) causing a local infl ammatory re- sponse3,4 (Fig. 34-2, A). 400 Females C-reactive protein (CRP), a nonspecifi c marker of infl amma- tion, is increased in many patients with CAD. Chronic exposure to 300 288,768 268,503 even minor elevations of CRP can trigger the rupture of plaques Cardiovascular System Cardiovascular and promote the oxidation of low-density lipoprotein (LDL) cho- 200 lesterol, leading to increased uptake by macrophages in the endo- 5,6 64,103 thelial lining. Deaths in thousands 69,257 41,877 100 60,713 Developmental Stages. CAD is a progressive disease that 34,301 38,948 takes many years to develop. When it becomes symptomatic, the 0 disease process is usually well advanced. The stages of development ABCDE ABDEF in atherosclerosis are (1) fatty streak, (2) fi brous plaque resulting from smooth muscle cell proliferation, and (3) complicated lesion. A Total CVD (Preliminary) D Chronic Lower Respiratory Diseases B Cancer E Diabetes Mellitus Fatty Streak. Fatty streaks, the earliest lesions of atherosclero- 2 C Accidents F Alzheimer’s Disease sis, are characterized by lipid-fi lled smooth muscle cells. As streaks of fat develop within the smooth muscle cells, a yellow FIG. 34-1 Leading causes of death for all men and women. CVD, Cardiovas- cular disease. tinge appears. Fatty streaks can be observed in the coronary arter- ies by age 15 and involve an increasing amount of surface area as the patient ages.
    [Show full text]